BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6447785)

  • 41. In vitro effects of thymosin, testosterone and growth hormone on antibody formation in murine spleen cells.
    Deschaux P; Ulrich T; Goldstein AL
    Thymus; 1980 Jan; 1(4-5):287-91. PubMed ID: 7003826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of immunoglobulin secreting cells in the human autologous mixed leukocyte reaction: regulation by helper and suppressor lymphocyte subsets defined with monoclonal antibodies.
    Gatenby PA; Kotzin BL; Engleman EG
    J Immunol; 1981 Nov; 127(5):2130-5. PubMed ID: 6457864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of thymosin on T-lymphocyte functions in patients with acute thermal burns.
    Ishizawa S; Sakai H; Sarles HE; Larson DL; Daniels JC
    J Trauma; 1978 Jan; 18(1):48-52. PubMed ID: 146096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
    J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro effect of calf thymosin on T cell of cancer patients].
    Ye M
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):245-8. PubMed ID: 6984676
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro and in viro effects of the fifth thymosin fraction.
    Litvinov VI; Averbakh MM; Novoselova VN; Gergert VY; Markov AN; Moroz AM
    Folia Biol (Praha); 1977; 23(3):218-21. PubMed ID: 328318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 49. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
    Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S
    J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of thymosin treatment on antituberculous immunity in immunosuppressed mice.
    Collins FM; Auclair LK
    J Reticuloendothel Soc; 1979 Aug; 26(2):143-53. PubMed ID: 385871
    [No Abstract]   [Full Text] [Related]  

  • 51. Thymic hormones and immunopeptides.
    Khan A
    Ann Allergy; 1978 Aug; 41(2):78-83. PubMed ID: 308333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ability of thymosin to decrease in vivo and in vitro suppressor cell activity in tumor bearing mice and cancer patients.
    Serrou B; Cupissol D; Caraux J; Thierry C; Rosenfeld C; Goldstein AL
    Recent Results Cancer Res; 1980; 75():110-4. PubMed ID: 6453408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential role of thymosin in the treatment of autoimmune diseases.
    Goldstein AL; Zatz MM; Low TL; Jacobs R
    Ann N Y Acad Sci; 1981; 377():486-95. PubMed ID: 6462093
    [No Abstract]   [Full Text] [Related]  

  • 54. In vitro activation of human suppressor cells: relative quantitation and specificity of suppressor cells generated in primary and secondary mixed lymphocyte cultures.
    Hess AD; Tutschka PJ; Santos GW
    Exp Hematol; 1981 Apr; 9(4):415-30. PubMed ID: 6453719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allosensitized T cells produce soluble factors susceptible to suppress allogeneic proliferation but not to interfere on cell mediated cytotoxicity.
    Carosella E; Bensussan A; Dausset J; Sasportes M
    Medicina (B Aires); 1981; 41 Suppl():65-76. PubMed ID: 6212736
    [No Abstract]   [Full Text] [Related]  

  • 56. Non-specific inhibitory processes of immunological and mitogenic cellular responses.
    Liacopoulos M; Lambert F; Liacopoulos P
    Immunology; 1980 Sep; 41(1):143-52. PubMed ID: 6448806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can drugs increase the immune response?
    Kent S
    Geriatrics; 1977 Jul; 32(7):101-13. PubMed ID: 326618
    [No Abstract]   [Full Text] [Related]  

  • 58. Generation of CD8+ suppressor T cells by protoscoleces of Echinococcus multilocularis in vitro.
    Kizaki T; Ishige M; Bingyan W; Day NK; Good RA; OnoƩ K
    Immunology; 1993 Jul; 79(3):412-7. PubMed ID: 8104883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thymosin modulation of suppressor function in mice and man.
    Serrou B; Rosenfeld C; Caraux J; Thierry C; Cupissol D; Goldstein A
    Ann N Y Acad Sci; 1979; 332():95-100. PubMed ID: 161154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biologic activity of an idiotype-bearing suppressor T cell factor produced by a long-term T cell hybridoma.
    Takaoki M; Sy MS; Whitaker B; Nepom J; Finberg R; Germain RN; Nisonoff A; Benacerraf B; Greene MI
    J Immunol; 1982 Jan; 128(1):49-53. PubMed ID: 6459378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.